Melatonin Ameliorates Tacrolimus (FK-506)'s Induced Immunosupressive Effect in Rat Liver
dc.authorid | bay karabulut, aysun/0000-0002-7873-2805 | |
dc.authorwosid | bay karabulut, aysun/HJP-0995-2023 | |
dc.contributor.author | Karabulut, A. B. | |
dc.contributor.author | Ara, C. | |
dc.date.accessioned | 2024-08-04T20:31:15Z | |
dc.date.available | 2024-08-04T20:31:15Z | |
dc.date.issued | 2009 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Tacrolimus (FK-506) is a powerful immunosuppressive agent that modulates neutrophil infiltration during inflammation. In this study, we sought to investigate the effects of melatonin on malondialdehyde (MDA), nitric oxide (NO), interleukin (IL)-6, and tumor necrosis factor-alpha (TNF-alpha) to oppose the negative effects of the immunosupressant FK-506. Group A was sham; group B, tacrolimus (1 mg/kg/d subcutaneously); and Group C received tacrolimus (1 mg/kg/d plus melatonin). All tissues underwent histopathologic examination. The MDA level in group B increased 53% compared with the sham group (P < .001); in group C, the MDA level decreased 1.6% compared with group B (P > .05). While TNF-alpha in group B increased 68.8% compared with the sham group (P < .001) and in group C it decreased 63.5% compared with the sham group. The IL-6 level in group B increased 81%; in group C, it decreased 13% compared with group B. NO levels in group B increased 48% compared with the sham group and increased by 15% in group B compared with group C. Thus melatonin may serve as a protective agent against the side effects of tacrolimus. | en_US |
dc.identifier.doi | 10.1016/j.transproceed.2008.12.035 | |
dc.identifier.endpage | 1877 | en_US |
dc.identifier.issn | 0041-1345 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 19545748 | en_US |
dc.identifier.scopus | 2-s2.0-67249117772 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1875 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2008.12.035 | |
dc.identifier.uri | https://hdl.handle.net/11616/94812 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000267449100097 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Transplantation Proceedings | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Ischemia-Reperfusion Injury | en_US |
dc.subject | Tumor-Necrosis-Factor | en_US |
dc.subject | Nitric-Oxide | en_US |
dc.subject | Pineal-Gland | en_US |
dc.subject | Fk506 | en_US |
dc.subject | Damage | en_US |
dc.subject | Transplantation | en_US |
dc.subject | Cyclosporine | en_US |
dc.subject | Antioxidant | en_US |
dc.subject | Metabolites | en_US |
dc.title | Melatonin Ameliorates Tacrolimus (FK-506)'s Induced Immunosupressive Effect in Rat Liver | en_US |
dc.type | Article | en_US |